Doctor Haotian Gu

King's College London, London (United Kingdom of Great Britain & Northern Ireland)

Membership: FESC Member

Contributor content

$First-phase ejection fraction, a measure of pre-clinical heart failure, is strongly associated with increased mortality in patients with COVID-19$

Presentation

First-phase ejection fraction, a measure of pre-clinical heart failure, is strongly associated with increased mortality in patients with COVID-19

$First-phase ejection fraction predicts response to cardiac resynchronization therapy and adverse outcomes$

Presentation

First-phase ejection fraction predicts response to cardiac resynchronization therapy and adverse outcomes

$Early systolic function is impaired in patients with heart failure and preserved ejection fraction and is a more important predictor of clinical outcomes than diastolic function$

Presentation

Early systolic function is impaired in patients with heart failure and preserved ejection fraction and is a more important predictor of clinical outcomes than diastolic function

$First-phase ejection fraction is a powerful predictor of adverse events in asymptomatic patients with aortic stenosis and preserved total ejection fraction$

Presentation

First-phase ejection fraction is a powerful predictor of adverse events in asymptomatic patients with aortic stenosis and preserved total ejection fraction

$Reduced first-phase ejection fraction in severe aortic stenosis patients with preserved overall ejection fraction$

Presentation

Reduced first-phase ejection fraction in severe aortic stenosis patients with preserved overall ejection fraction

Explore sponsored resources

Doctor Haotian Gu

Contributor content

First-phase ejection fraction, a measure of pre-clinical heart failure, is strongly associated with increased mortality in patients with COVID-19

First-phase ejection fraction predicts response to cardiac resynchronization therapy and adverse outcomes

Early systolic function is impaired in patients with heart failure and preserved ejection fraction and is a more important predictor of clinical outcomes than diastolic function

First-phase ejection fraction is a powerful predictor of adverse events in asymptomatic patients with aortic stenosis and preserved total ejection fraction

Reduced first-phase ejection fraction in severe aortic stenosis patients with preserved overall ejection fraction

ESC 365 is supported by